Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 12

Cost-effectiveness analysis of umeclidinium/vilanterol for the management of patients with moderate to very severe COPD using an economic model

Total article views   HTML views PDF downloads Totals
8,985 Dovepress* 7,447+ 1,745 9,192
PubMed Central* 1,538 552 2,090
Totals 8,985 2,297 11,282
*Since 24 March 2017
Total mentioned Facebook Delicious Reddit Twitter Others
6 1 0 0 1 4

View citations on PubMed Central and Google Scholar